Thanks for joining us Fizzah. Amazing turn out for 8am on day 2! Case based walk through always works well educationally, especially with such an engaged and knowledgable audience 👍 #BCISACI
A fantastic critical appraisal by cardiology’s favourite podcaster @drjohnm at #BCISACI provoking important questions on the impact of randomised device trials, framing the right questions and endpoints, and the role of journals & regulatory agencies
A most enjoyable discussion with @drjohnm :
From writing blogs on cycling to cardiology to podcasting, social media and being the trusted voice in contemporary critical appraisal
#BCISACI@AstercsDEX_
#ESCCongress 🇪🇸 2025: DAPT-SHOCK-AMI trial - Cangrelor in cardiogenic shock
🔗https://t.co/tspXyKRZMA
Read this review by @KVM83 and @ChoudryFizzah.
Bonus🎁: check out the written Q&A with Zuzana Motovska, PI and lead investigator of this trial!
#interventionalcardiology
@DrPaulRees is leaving @BartsIntervGrp for pastures new with an exciting new chapter in Minnesota where he will be leading with his expertise in the Cardiology and Cardiogenic Shock programme. @Ozkor@mdstbarts
In case you missed it, tomorrow's @BartsIntervGrp B.I.G. Evening Symposium on DCBs is approved by @RCPhysicians for 2 category CPD credits! Join guest speakers Dr Sandeep Basavarajaiah and
@DrLucaTesta alongside @ChoudryFizzah@krishnaraj82 and @Bhcintervention for an in-depth look at #DrugCoatedBalloons. Don't worry, dinner is included!
https://t.co/kFp7GJ4u8r